# Risk Factors for the Recurrent Postoperative Macular Edema Treated With OZURDEX

> **NCT05372562** · — · COMPLETED · sponsor: **Peking University** · enrollment: 30 (actual)

## Conditions studied

- Macular Edema

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05372562
- **Lead sponsor:** Peking University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-01
- **Primary completion:** 2022-04-30
- **Final completion:** 2022-04-30
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05372562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05372562, "Risk Factors for the Recurrent Postoperative Macular Edema Treated With OZURDEX". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05372562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*